Advertisement

Payer

The financial headwinds facing major Medicare Advantage carriers are also affecting companies across the Blue Cross Blue Shield system.

Around 1 in 3 employers covered GLP-1 drugs for weight loss in 2023, a survey from the International Foundation of Employee Benefit Plans found. 

Advertisement

The majority of ACA marketplace plans cover GLP-1 drugs approved for diabetes, though fewer than 1% of plan formularies include drugs solely approved to treat obesity, a new analysis from KFF shows. 

Here are five lawsuits, settlements and legal developments involving payers that Becker's has reported since May 22: 

From Kraft Heinz suing Aetna for alleged mismanagement of employee claims data to Elevance Health being sued by contracted labor unions for reportedly restricting claims data access, certain third-party health plan administrators are being forced to answer the big questions…

Advertisement